BCAT1, as a prognostic factor for HCC, can promote the development of liver cancer through activation of the AKT signaling pathway and EMT

Yifeng Ding; Qingquan Liu; Aijun Lai; Xiaodong He; Shaowei Lu; Xiaoqing Wang; Binhui Xie

doi:10.1007/s10735-022-10108-3

BCAT1, as a prognostic factor for HCC, can promote the development of liver cancer through activation of the AKT signaling pathway and EMT

Yifeng Ding(University of Illinois Urbana-Champaign), Qingquan Liu(Capital University), Aijun Lai(First Affiliated Hospital of Gannan Medical University), Xiaodong He(Chinese Academy of Medical Sciences & Peking Union Medical College), Shaowei Lu(First Affiliated Hospital of Gannan Medical University), Xiaoqing Wang(Roche (China)), Binhui Xie(First Affiliated Hospital of Gannan Medical University)

Journal of Molecular Histology

November 7, 2022

10.1007/s10735-022-10108-3

Cited by 25

|International Journal of Molecular Sciences|2018|1.4k

Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute

|Nature Protocols|2019|485

Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade

|Cancer Discovery|2021|286

Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer

|Science Advances|2023|220

In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target

|Cell|2021|200

BCAT1, as a prognostic factor for HCC, can promote the development of liver cancer through activation of the AKT signaling pathway and EMT

Related Papers